Investors Buy UnitedHealth Group Incorporated (UNH) on Weakness After Insider Selling
Traders bought shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading hours on Tuesday after an insider sold shares in the company. $234.82 million flowed into the stock on the tick-up and $141.69 million flowed out of the stock on the tick-down, for a money net flow of $93.13 million into the stock. Of all equities tracked, UnitedHealth Group had the 3rd highest net in-flow for the day. UnitedHealth Group traded down ($3.54) for the day and closed at $194.65Specifically, Director William C. Ballard, Jr. sold 5,000 shares of the stock in a transaction dated Thursday, August 3rd. The shares were sold at an average price of $193.98, for a total value of $969,900.00. Following the completion of the sale, the director now owns 76,058 shares in the company, valued at $14,753,730.84. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the firm’s stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the sale, the director now owns 1,818,898 shares of the company’s stock, valued at approximately $348,700,935.58. The disclosure for this sale can be found here. In the last quarter, insiders sold 76,174 shares of company stock valued at $14,981,909. 0.89% of the stock is currently owned by corporate insiders.
UNH has been the subject of a number of research analyst reports. UBS AG restated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, August 24th. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $199.00 price objective for the company in a report on Tuesday, May 30th. BidaskClub upgraded shares of UnitedHealth Group from a “buy” rating to a “strong-buy” rating in a report on Saturday, July 8th. Morgan Stanley raised their price objective on shares of UnitedHealth Group from $202.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, June 28th. Finally, Vetr upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $186.50 price objective for the company in a report on Tuesday, May 30th. One investment analyst has rated the stock with a hold rating and twenty-five have assigned a buy rating to the company’s stock. UnitedHealth Group has a consensus rating of “Buy” and an average price target of $203.41.
The company’s 50-day moving average price is $195.48 and its 200-day moving average price is $181.07. The stock has a market capitalization of $188.20 billion, a P/E ratio of 23.38 and a beta of 0.63.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The business had revenue of $50.05 billion during the quarter, compared to the consensus estimate of $49.97 billion. During the same period in the prior year, the company posted $1.96 EPS. The firm’s revenue for the quarter was up 7.7% compared to the same quarter last year. Equities research analysts predict that UnitedHealth Group Incorporated will post $9.87 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th will be paid a $0.75 dividend. The ex-dividend date is Thursday, September 7th. This represents a $3.00 annualized dividend and a yield of 1.54%. UnitedHealth Group’s payout ratio is 35.13%.
A number of hedge funds have recently bought and sold shares of UNH. Patriot Financial Group Insurance Agency LLC boosted its position in shares of UnitedHealth Group by 1,722.9% during the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 638 shares of the healthcare conglomerate’s stock valued at $106,000 after acquiring an additional 603 shares during the last quarter. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $110,000. Kings Point Capital Management boosted its position in shares of UnitedHealth Group by 27.9% during the 1st quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after acquiring an additional 150 shares during the last quarter. Bruderman Asset Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $114,000. Finally, Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in shares of UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after acquiring an additional 520 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.